1 / 9

Principles of Drug Design

Principles of Drug Design. Enzyme Inhibition Basics . Example: 1) Statins (I) inhibit HMG CoA Reductase (E); S = HMG CoA; P = Mevalonate 2) I = Warfarin, E = reductase, S = vitamin K epoxide, P = vitamin K

Jims
Télécharger la présentation

Principles of Drug Design

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Principles of Drug Design • Enzyme Inhibition Basics Example: 1) Statins (I) inhibit HMG CoA Reductase (E); S = HMG CoA; P = Mevalonate 2) I = Warfarin, E = reductase, S = vitamin K epoxide, P = vitamin K Other examples: salicyclic acid, physostigmine, sulfanilamide, captopril, enalapril, finasteride, …… Units of KI and IC50 = M MEDC 603 Fall 2007

  2. kCAT E + S E:S P + E KM KI I E:I Principles of Drug Design • Competitive Inhibition + + S S E P E E I E I MEDC 603 Fall 2007

  3. Principles of Drug Design • Competitive Inhibition …. Example Design of Statins Substrate Inhibitor MEDC 603 Fall 2007

  4. Principles of Drug Design • Competitive Inhibition …. Example AZT  potent inhibitor of HIV-RT, the retroviral polymerase which catalyzes the formation of proviral DNA from viral RNA. MEDC 603 Fall 2007

  5. + S + S E P E E I E S + P E I Principles of Drug Design • Non-Competitive Inhibition MEDC 603 Fall 2007

  6. Exosite II Thrombin Active Site Exosite I Principles of Drug Design • Non-Competitive Inhibition … Example Thrombin Thrombin Bivalirudin Argatroban Competitive Non-competitive H2N-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly HOOC-Leu-Tyr-Glu-Glu-Pro-Ile-Glu-Glu-Phe-Asp Bivalirudin Argatroban MEDC 603 Fall 2007

  7. Principles of Drug Design • Non-Competitive Inhibition … Example Nevirapine  potent inhibitor of HIV-RT … KI ~ nM … no resemblance to any of the natural nucleotide substrates … binds in a hydrophobic binding pocket adjacent to the substrate-binding pocket and modifies the rate of polymerization. MEDC 603 Fall 2007

  8. E + S E:S Response E:I E:S:I Principles of Drug Design • Differentiation of type of inhibition MEDC 603 Fall 2007

  9. E + S E:S E-S No further rxn. Principles of Drug Design • Irreversible Inhibition Substrate behaves as an inhibitor! aka …. Suicide substrate inhibitors or Mouse trap inhibitors or Trojan horse inhibitors MEDC 603 Fall 2007

More Related